tive IGRAs that may improve on the limitations of QFT.
Multidrug-resistant

Enterococcus faecium in a Patient with Burns
Enterococcus species represent an important nosocomial pathogen. In the United States between 1992 and 1999, intensive care unit-associated enterococcal infections accounted for 13.5% of primary bloodstream infections, 1.7% of pneumonia infections, and 13.8% of urinary tract infections [1] . In recent years, concern has been expressed regarding the increase in antimicrobial resistance among enterococci [2, 3] . Enterococci are intrinsically resistant to many antibiotics, including the cephalosporins, semisynthetic penicillins, and aminoglycosides. Acquired resistance to penicillins, macrolides, fluoroquinolones, and vancomycin has been frequently described. 
